Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_provenance.
- NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_assertion description "[The frequency of particular forms of LGMD2 was 32.6% for LGMD2A (71 probands), 4.1% for LGMD2I (9 probands), 2.8% for LGMD2D (6 probands), and 1.4% for LGMD2L (3 probands).Further, we present the first results of a new approach established in the Czech Republic for diagnosis of neuromuscular diseases: sequence capture and targeted resequencing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_provenance.
- NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_assertion evidence source_evidence_literature NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_provenance.
- NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_assertion SIO_000772 25135358 NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_provenance.
- NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_assertion wasDerivedFrom befree-2016 NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_provenance.
- NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_assertion wasGeneratedBy ECO_0000203 NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1211767.RAhxlCEco9n6HVhEuo_cR_IhLqzhP8Wko_J0yog7ssSzw130_provenance.